Description
Taylor & Francis Lung Tumors Fundamental Biology and Clinical Management 1998 Edition by Christian Brambilla
This thoroughly up-to-date reference addresses new approaches to the diagnosis, management, and treatment of lung tumors, providing the insights of fundamental biologists, surgical pathologists, and clinicians. Featuring research from over 75 internationally recognized experts in the field, Lung Tumorsdetails the key factors of lung tumor carcinogenesis analyzes multimodality treatments using chemotherapy and fractionated radiotherapy reviews telomerase activation as well as the p53 and Rb pathways investigates the FHIT gene and gene hypermethylation elucidates the complex relationship between host and tumor highlights angiogenesis and the clonal evolution of preneoplastic lesions profiles the differential diagnosis between primary and secondary tumors examines the rare and borderline malignancies and more! Containing nearly 3000 references, drawings, photographs, and micrographs, Lung Tumors serves as an excellent reference for pulmonologists and pulmonary disease specialists, physiologists, respiratory and thoracic surgeons, oncologists, pathologists and surgical pathologists, molecular and cellular biologists, lung radiologists, medical school and graduate students in these disciplines. Table of contents :- Clinicopathological Entities The Need for a New Classification for Lung and Pleural Tumors, William D.Travis and Thomas V. ColbyBasaloid Carcinomas of the Lung, Elisabeth Brambilla and Denis MoroNeuroendocrine Tumors of the Lung, William D. TravisPrecursor Lesions to Pulmonary Neoplasia, Thomas V. ColbyPulmonary Lymphoproliferative Disorders, Andrew G. NicholsonRare Pulmonary Tumors and Borderline Malignancies, Cesar A. Moran and Saul SusterDifferential Diagnosis Between Primary and Metastatic Carcinomas, Philip T. CagleCell Cycle Control and Molecular Pathology ras Mutation in Lung Cancer, Daniel R. JacobsonDeletions of the Short Arm of Chromosome 3 and the FHIT Gene in Lung Cancer, Gabriella SozziP53 Pathway and Lung Cancer, Elisabeth Brambilla and Sylvie GazzeriInactivation of RB Gene and pRB Function in Lung Cancer, Sylvie Gazzeri and Valerie GouyerDeregulation of the Cell Cycle in Lung Cancer, R.J.A.M. MichalidesRelevance of DNA Methylation to Lung Cancer, Samir M. Hanash, Bruce Richardson, and David BeerPreneoplastic Lesions and Early Detection of Lung Cancer Clinical Basis for Early Detection of Lung Cancer, Kell Osterlind and Fred R. HirschGenetic Instability Assessments in the Lung Cancerization Field, Walter N. HittelmanTelomerase and Lung Cancer, Asha Rathi, Yashima Kazuo, Naoyoshi Onuki, Arvind Virmani, and Adi F. GazdarClonal Development of Lung Cancer, Grace Chung and Pamela RabbittsSelection and Validation of New Lung Cancer Markers for the Molecular-Pathological Assessment of Individuals with a High Risk of Developing Lung Cancer, J.K. FieldRetinoids for Lung Cancer Intervention, Ugo PastorinoAntioxidants and the Chemoprevention of Lung Cancer, Nico van Zandwijk and L. Van'T VeerIntegrated Approach to the Management of Early Lung Cancer, James L. Mulshine, Anthony M. Treston, Melvyn S. Tockman, and Frank CuttittaHost-Tumor Relationship Role of Growth Factors in the Stromal Reaction in Non-Small-Cell Lung Carcinoma, Jean-Michel Vignaud, Yves Martinet, and Nadine Martinet Tumor Angiogenesis, Fabrice Soncin and Bernard Vandenbunder Angiogenesis in Lung Cancer, Francesco Pezzella, Ugo Pastorino, and Kevin C. GatterMatrix Proteases and Transcription Factors in the Process of Dissemination, Isabelle Bolon and Catherine RobertAdhesion Molecules, Jean-Louis Pujol and Pascal DemolyClinical Management Tumor Markers: Clinical Meaning and Use, Gianfranco Buccheri The p53 Tumor Suppressor Gene: From Molecular Biology to Clinical Investigation, Thierry SoussiEndoscopic Detection of Preneoplastic Lesions, Stephen C. Lam and Calum MacAulayAdvances in Lung Cancer Imaging, Gilbert Ferretti, Jean-Philippe Vuillez, and Max CoulombRadioimmunodetection and Radioimmunotherapy in Lung Cancer, Jean-Philippe Vuillez and Denis MoroPhotodynamic Therapy for Lung Cancer, Eric S. Edell and Denis A. CorteseEndobrachial Brachytherapy, M. Taulelle, P. Vincent, B. Chauvet, R. Garcia, and Francois L. ReboulMultimodality Therapy in Locally Advanced Non-Small-Cell Lung Cancer (NSCLC Stage IIIB), Jean-Charles Soria, Therry Le Chevalier, Cecile Le Pechoux, and Rodrigo ArriagadaProgress in Chemotherapy in Advanced Non-Small-Cell Lung Cancer, Alain DepierrePrognostic Factors in Unresectable Non-Small-Cell Lung Cancer, E. QuoixConventional Radiotherapy and New Approaches to Lung Cancer, Paul Van Houtte and Francois MornexChemotherapy in Small-Cell Lung Cancer: Is More Better?, Fabrizio M. Facchini and Stephen G. SpiroOptimal Integration of Chemotherapy and Thoracic Irradiation in Limited-Stage Small-Cell Lung Cancer, Nevin MurrayLong-Term Survivors of Small-Cell Lung Cancer, Late Effects of Treatment, and Second Cancers, Pascale Jacoulet and Denis MoroNew Drugs for New Chemotherapy Standards, Giorgio V. Scagliotti and Silvia NovelloLung Metastases and Second Lung Cancer: Role of Surgery, Ugo Pastorino and Francesco PezzellaOccupational Lung Cancer, Yves Martinet, Philippe Scheid, Jean-Michel Vignaud, Nadine Martinet, and Jean-Jacques MoulinLung Cancer Cell Immunogenicity and Immunotherapy, Patrick WeynantsGene Therapy, Christian Brambilla, Adrien Negoescu, Marie Favrot, and Jean-Luc Coll